| Bioactivity | PKCθ pseudosubstrate peptide inhibitor, myristoylated TFA is a synthetic peptide that can be used to study the mechanism of action of PKCθ[1]. | ||||||
| Sequence | {Myr}-Leu-His-Gln-Arg-Arg-Gly-Ala-Ile-Lys-Gln-Ala-Lys-Val-His-His-Val-Lys-Cys-NH2 | ||||||
| Shortening | {Myr}-LHQRRGAIKQAKVHHVKC-NH2 | ||||||
| Formula | C105H184N36O21S.xC2HF3O2 | ||||||
| Molar Mass | 2318.88 (free base) | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Koon HW, et al. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation. J Pharmacol Exp Ther. 2005 Sep;314(3):1393-400. |
PKCθ pseudosubstrate peptide inhibitor,myristoylated TFA
CAS: F: C105H184N36O21S.xC2HF3O2 W: 2318.88 (free base)
PKCθ pseudosubstrate peptide inhibitor, myristoylated TFA is a synthetic peptide that can be used to study the mechanis
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.